medigus.com (XYLO) Long-Term Liabilities to Capital

Xylo Technologies Ltd. (XYLO) is a diversified tech holding company establishing itself as a pioneer in microsurgery and biomedicine. Business resilience is underpinned by the ownership of highly specialized IT services and an extensive patent portfolio. Current price action on GURU.Markets, where the individual debt-to-equity ratio stands at 0.03, highlights growth potential driven by startup monetization and the expansion of its digital retail footprint.

When screening assets, an investor evaluates long-term solvency through the debt-to-equity ratio. This metric measures the proportion of borrowed funds with a maturity exceeding one year within the financing structure. For Xylo Technologies Ltd. (XYLO), this is critical when complying with stringent cybersecurity standards and protecting unique IT code. Debt optimization reduces bankruptcy risks. The historical trend of the long-term debt-to-equity ratio clearly demonstrates the current balance between stability and profitability.